Why is "Lisdexamfetamine" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-16 12:53:03
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Lisdexamfetamine entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-16 and was most recently seen on 2026-03-16.
Wikipedia Overview
Lisdexamfetamine, sold under the brand names Vyvanse (/'vai.væns/) and Elvanse among others, is a stimulant medication that is used as a treatment for attention deficit hyperactivity disorder (ADHD) in both children and adults, and for moderate-to-severe binge eating disorder in adults. A prodrug of dextroamphetamine, lisdexamfetamine is taken by mouth. Its effects generally begin within 90 minutes and last for up to 14 hours.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Liquid Formulation of Lisdexamfetamine Expands Options for Patients With ADHD - Psychiatric Times
-
Azurity Pharmaceuticals Announces the Availability of ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution, CII - Yahoo Finance
-
Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications - Wiley Online Library
-
FDA Announces Nationwide Recall of ADHD Medication—Check Your Cabinets Now - health.com
-
A Nationwide Recall of 8,500 ADHD Medication Bottles Just Received an Update from the FDA - The Healthy @Reader's Digest
-
Stada Joins Effort To Void Takeda's ADHD Drug IP In UK - Law360
-
Generic Vyvanse may not be working like it should. What to know about nationwide recall - Shreveport Times
-
Several lots of ADHD medication recalled over failed tests - cbs8.com
-
FDA announces recall of common ADHD drug prescribed in CT and nationwide - CTPost
-
Lisdexamfetamine Dimesylate Oral Solution for ADHD to Be Available Mid-2026 - Psychiatric Times
-
ADHD medication recalled nationwide because users aren’t getting the full effect - WDBJ7
-
Is There a Generic for Vyvanse? Forms, Shortage, and More - GoodRx
-
Nationwide Recall Alert: ADHD Drug May Not Dissolve Correctly - HealthDay
-
FDA recalls commonly prescribed ADHD medication over failed lab tests - Syracuse.com
-
Takeda lifts guidance as growth brands offset Vyvanse drag - The Pharma Letter
-
Common ADHD Medication Recalled Nationwide - Parents
-
Nationwide ADHD Medication Recall Update as FDA Sets Risk Level - Newsweek
-
ADHD medicines prescriptions rose again in 2025 - The Pharmaceutical Journal
-
ADHD medication being recalled nationwide after failing effectiveness tests - The Independent
-
ADHD medication recall: several lots pulled after tests - Houston Chronicle
-
Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review - Wiley Online Library
-
Common Treatment for Binge Eating Disorder Shows Mixed Results - Rutgers University
-
Takeda Hits Back At Stada's ADHD Drug IP Challenge - Law360
-
Sun Pharma recalls ADHD drug Lisdexamfetamine' in US - pharma.economictimes.indiatimes.com
-
Nationwide Recall Issued For ADHD Medication Affecting Millions - DailyVoice.com
-
Top 10 ADHD News & Research Headlines of 2024 - ADDitude
-
Lisdexamfetamine’s Efficacy in Treating Attention Deficit Hyperactivity Disorder (ADHD): A Meta-Analysis and Review - Cureus
-
Takeda Defends UK Patent Protection For ADHD Drug Elvanse - Law360
-
ADHD Medication Not Working? Here’s What Could Be Going On - Yahoo Creators
-
FDA approves multiple lisdexamfetamine dimesylate generics for ADHD in children - Contemporary Pediatrics
-
Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder - Psychiatry Online
-
Lisdexamfetamine maintenance treatment for binge-eating disorder following successful treatments: randomized double-blind placebo-controlled trial - Cambridge University Press & Assessment
-
Vyvanse Shortage Update: DEA OKs Expanded Production of the ADHD Medication - ADDitude
-
From Ritalin to Qelbree: 7 Vyvanse Alternatives to Consider - GoodRx
-
Generic Vyvanse: Does It Work the Same? Quality & Shortage Concerns - MedShadow Foundation
-
Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial - Psychiatry Online
-
Lisdexamfetamine Dimesylate (LDX) in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) - Docwire News
-
Lisdexamfetamine‐Induced Angioedema and Leukocytoclastic Vasculitis: A Case Report - Wiley Online Library
-
ADHD Medications and Cardiovascular Effects: New Data - Medscape
-
New study shows stimulants work on brain reward, motivation, and wakefulness. - Psychology Today
-
Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials - Nature
-
Lisdexamfetamine is effective in preschoolers with ADHD - Contemporary Pediatrics
-
Adderall and Vicks are illegal in Japan for North American travelers - Air Traveler Club
-
Risk of Incident Psychosis and Mania With Prescription Amphetamines - Psychiatry Online
-
Can’t fill your ADHD script? Here’s why, and what to do while the shortage persists - The Conversation
-
A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD - Psychiatrist.com
-
How to manage ADHD medicine shortages - australianpharmacist.com.au
-
‘No issues of concern’ with Vyvanse: TGA - Royal Australian College of General Practitioners (RACGP)
-
U.S. allows ADHD drugmaker to increase production limit to ease ongoing shortage - NBC News
-
FDA Approves First Generic Versions of Vyvanse - MPR - Medical Professionals Reference
-
Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder - Psychiatry Online
-
Many ADHD Medications Lead to Increases in Blood Pressure and Heart Rate - Physician's Weekly
-
Verdict in from regulator’s ADHD med review - Medical Republic
-
Lisdexamfetamine Reduces Symptoms of Cognitive Sluggishness in Adult Patients With ADHD - Pharmacy Times
-
Patients Seek Alternative ADHD Medications Amid Continuing Adderall Shortage - GoodRx
-
FDA Recalled The Common ADHD Medication Vyvanse - Health and Me
-
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD) - PR Newswire
-
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate - Business Wire
-
ADHD prescriptions surge – as drug misuse skyrockets - Indaily
-
New ADHD Medication in Norway - Mynewsdesk
-
Amid Shortages, U.S. Allows Expanded Production of ADHD Drug Vyvanse - Physician's Weekly
-
Amphetamines probably the best first-choice treatment for adults with ADHD - NIHR
-
Alarm over ADHD drug explosion and ‘diagnosis on demand’ - The Australian
-
newsGP - ADHD med shortage set to end - Royal Australian College of General Practitioners (RACGP)
-
Methylphenidate and (lis)dexamfetamine toxicity‐related deaths of adults, Australia, 2000–24: analysis of NCIS data - Medical Journal of Australia (MJA)
-
Pharmacy cops $15k hit on Vyvanse price cut - Australian Journal of Pharmacy
-
Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder - Frontiers
-
Drug Relieves Persistent Daydreaming, Fatigue & Brain Sluggishness in Adults with ADHD - NYU Langone Health
-
Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties | Neuropsychopharmacology - Nature
-
newsGP - TGA investigates spike in Vyvanse adverse event reports - Royal Australian College of General Practitioners (RACGP)
-
More Than 8,500 Bottles of a Trusted ADHD Medication Have Been Recalled Nationwide - The Healthy @Reader's Digest
-
ADHD drug shows promise for treating methamphetamine dependence - Medical Xpress
-
A Trusted ADHD Medication Has Been Recalled Nationwide - The Healthy @Reader's Digest
-
Amid ADHD drug shortage, industry group points a finger at government manufacturing restrictions: report - Fierce Pharma
-
Improving access for patients: launch of Lisdexamfetamine further broadens Sandoz Canada portfolio - GlobeNewswire
-
ADHD medication for amphetamine addiction linked to reduced risk of hospitalisation and death - Karolinska Institutet
-
Unmasking Risks: Hidden Dangers of ADHD & Mental Health Meds - The People's Pharmacy
-
Government issues 'out of stock' alert in update on ADHD medication shortage - Manchester Evening News
-
DEA allows ramped up production of ADHD meds - Axios
-
Amneal Receives FDA Approval for Lisdexamfetamine Dimesylate - Pharmacy Practice News
-
Amid Shortages, U.S. Allows Expanded Production of ADHD Drug Vyvanse - HealthDay
-
Many ADHD Medications Lead to Increases in Blood Pressure and Heart Rate - Diabetes In Control
-
DEA raises production limits on Takeda's ADHD drug Vyvanse and generics as shortages continue - Fierce Pharma
-
Amneal receives U.S. FDA approval for lisdexamfetamine dimesylate - Chain Drug Review
-
Novel ADHD Therapy More Tolerable, Less Effective Than Current Treatment Options - Drug Topics
-
Amneal obtains FDA OK for generic Vyvanse - Drug Store News
-
ADHD drug shows promise for treating methamphetamine dependence - Scimex
-
ADHD Patients Receive Promising News - Psychiatrist.com
-
ADHD medication for amphetamine addiction linked to reduced risk of hospitalization and death - Medical Xpress
-
US allows ADHD drugmaker to increase production limit amid ongoing shortage - WCNC
-
Australia's most common ADHD drug has had a spike in adverse event reports - ABC News & Headlines – Australian Broadcasting Corporation
-
New study finds safe and feasible treatment option for methamphetamine withdrawal - UNSW Sydney
-
How a drug for ADHD is being used to fight binge eating - The Conversation
-
ADHD Drug Helps Women With Menopause-Related Cognitive Issues in Study - Medical Professionals Reference
-
Mallinckrodt receives FDA nod for generic Vyvanse - Drug Store News
-
Hopeful News for Users of One A.D.H.D. Drug (Published 2024) - The New York Times
-
Researchers Find Industry Bias in Medical Education for Binge Eating Disorder - Mad In America
-
Hikma launches generic Vyvanse - Drug Store News
-
Stimulant reduces ‘sluggish cognitive tempo’ in adults with ADHD - MDEdge
-
Granules India receives USFDA approval for Lisdexamfetamine Dimesylate capsules - pharma.economictimes.indiatimes.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.